IRCT20200502047277N5
Recruiting
Phase 1
Safety and Therapeutic Effect of Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Children with Cerebral Palsy: Clinical Trial Phase I-II
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Enrollment
- 46
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Definitive diagnosis of cerebral palsy
- •No seizures or with controlled seizures
- •Parental consent
Exclusion Criteria
- •Severe cognitive disease
- •Hydrocephalus
- •Coagulation diseases
- •Have diseases such as cancer, active infections and heart, kidney and liver diseases
- •Evidence of a progressive neurological disease
- •Evidence of a genetic disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A safety and efficacy study of autologous bone marrow cell transplantation for cirrhosis of liver caused by lifestyle related diseaseCirrhosis of liver caused by lifestyle related disease(Including NASH)JPRN-UMIN000015251Heart life hospital10
Completed
Not Applicable
A safety and efficacy study of autologous bone marrow cell transplantation for HIV positive patients with cirrhosisHIV infection, AIDS, CirrhosisJPRN-UMIN000005174ational Center for Global Health and Medicine10
Completed
Not Applicable
Efficacy Stem Cell in Treatment AutismAutism.Childhood autismIRCT201512315280N22Mashhad University of Medical Sciences36
Recruiting
Phase 1
Autologous Mesenchymal Stem Cell Therapy in LupusHealth Condition 1: null- Systemic lupus erythematosusCTRI/2015/04/005716KIMS Foundation and Research Center and Krishna Institute of Medical Sciences10
Completed
Phase 1
Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke PatientsIschemic StrokeNCT00859014The University of Texas Health Science Center, Houston25